These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 29393333)
1. A 65‑gene signature for prognostic prediction in colon adenocarcinoma. Jiang H; Du J; Gu J; Jin L; Pu Y; Fei B Int J Mol Med; 2018 Apr; 41(4):2021-2027. PubMed ID: 29393333 [TBL] [Abstract][Full Text] [Related]
2. A 63 signature genes prediction system is effective for glioblastoma prognosis. Zhang Y; Xu J; Zhu X Int J Mol Med; 2018 Apr; 41(4):2070-2078. PubMed ID: 29393370 [TBL] [Abstract][Full Text] [Related]
3. Identification of a 5-Gene Cuproptosis Signature Predicting the Prognosis for Colon Adenocarcinoma Based on WGCNA. Wang D; Yang F; Han G; Zhang J; Wang H; Xiao Z; Chen W; Li P Technol Cancer Res Treat; 2024; 23():15330338241250285. PubMed ID: 38802999 [No Abstract] [Full Text] [Related]
4. A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures. Jin L; Li C; Liu T; Wang L Hum Genomics; 2020 Jun; 14(1):24. PubMed ID: 32522293 [TBL] [Abstract][Full Text] [Related]
5. Identification of Prognostic Biomarkers and Drugs Targeting Them in Colon Adenocarcinoma: A Bioinformatic Analysis. Dong S; Ding Z; Zhang H; Chen Q Integr Cancer Ther; 2019; 18():1534735419864434. PubMed ID: 31370719 [No Abstract] [Full Text] [Related]
6. A 15-gene signature for prediction of colon cancer recurrence and prognosis based on SVM. Xu G; Zhang M; Zhu H; Xu J Gene; 2017 Mar; 604():33-40. PubMed ID: 27998790 [TBL] [Abstract][Full Text] [Related]
7. Construction of a prognostic prediction system for pancreatic ductal adenocarcinoma to investigate the key prognostic genes. Zheng B; Peng J; Mollayup A; Bakri A; Guo L; Zheng J; Xu H Mol Med Rep; 2018 Jan; 17(1):216-224. PubMed ID: 29115420 [TBL] [Abstract][Full Text] [Related]
8. Identification of Molecular Subtypes and a Prognostic Signature Based on Inflammation-Related Genes in Colon Adenocarcinoma. Qiu C; Shi W; Wu H; Zou S; Li J; Wang D; Liu G; Song Z; Xu X; Hu J; Geng H Front Immunol; 2021; 12():769685. PubMed ID: 35003085 [TBL] [Abstract][Full Text] [Related]
9. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer. Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J Gene; 2022 Mar; 813():146117. PubMed ID: 34902511 [TBL] [Abstract][Full Text] [Related]
10. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets. Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873 [TBL] [Abstract][Full Text] [Related]
11. Identification prognosis-associated immune genes in colon adenocarcinoma. Miao Y; Wang J; Ma X; Yang Y; Mi D Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821 [TBL] [Abstract][Full Text] [Related]
12. Identification of a prognostic gene signature of colon cancer using integrated bioinformatics analysis. Fang Z; Xu S; Xie Y; Yan W World J Surg Oncol; 2021 Jan; 19(1):13. PubMed ID: 33441161 [TBL] [Abstract][Full Text] [Related]
13. Using ESTIMATE algorithm to establish an 8-mRNA signature prognosis prediction system and identify immunocyte infiltration-related genes in Pancreatic adenocarcinoma. Meng Z; Ren D; Zhang K; Zhao J; Jin X; Wu H Aging (Albany NY); 2020 Mar; 12(6):5048-5070. PubMed ID: 32181755 [TBL] [Abstract][Full Text] [Related]
14. Construction of a Signature Composed of 14 Immune Genes to Judge the Prognosis and Immune Infiltration of Colon Cancer. Mo S; Pei Z; Dai L Genet Test Mol Biomarkers; 2021 Mar; 25(3):163-178. PubMed ID: 33734891 [No Abstract] [Full Text] [Related]
15. Colon cancer recurrence‑associated genes revealed by WGCNA co‑expression network analysis. Zhai X; Xue Q; Liu Q; Guo Y; Chen Z Mol Med Rep; 2017 Nov; 16(5):6499-6505. PubMed ID: 28901407 [TBL] [Abstract][Full Text] [Related]
16. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma. Wang Y; Wang Y; Liu F Int J Mol Med; 2018 Dec; 42(6):3105-3114. PubMed ID: 30272265 [TBL] [Abstract][Full Text] [Related]
17. Integrated bioinformatics analysis identified COL11A1 as an immune infiltrates correlated prognosticator in pancreatic adenocarcinoma. Zheng X; Liu X; Zheng H; Wang H; Hong D Int Immunopharmacol; 2021 Jan; 90():106982. PubMed ID: 33129696 [TBL] [Abstract][Full Text] [Related]
18. An eight-miRNA signature expression-based risk scoring system for prediction of survival in pancreatic adenocarcinoma. Dou D; Yang S; Lin Y; Zhang J Cancer Biomark; 2018; 23(1):79-93. PubMed ID: 29991127 [TBL] [Abstract][Full Text] [Related]
19. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma. Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203 [No Abstract] [Full Text] [Related]
20. Identification of key genes relevant to the prognosis of ER-positive and ER-negative breast cancer based on a prognostic prediction system. Xiao B; Hang J; Lei T; He Y; Kuang Z; Wang L; Chen L; He J; Zhang W; Liao Y; Sun Z; Li L Mol Biol Rep; 2019 Apr; 46(2):2111-2119. PubMed ID: 30888555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]